GREENWICH BIOSCIENCES Trademark

Trademark Overview


On Thursday, May 26, 2016, a trademark application was filed for GREENWICH BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the GREENWICH BIOSCIENCES trademark a serial number of 87050601. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 16, 2025. This trademark is owned by GW Research Limited. The GREENWICH BIOSCIENCES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, peri-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, MS spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, type II diabetes, obesity...
greenwich biosciences

General Information


Serial Number87050601
Word MarkGREENWICH BIOSCIENCES
Filing DateThursday, May 26, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 16, 2025
Registration Number5598310
Registration DateTuesday, November 6, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 21, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, peri-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, MS spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, type II diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse, autism; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, peri-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, MS spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, type II diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse, autism; pure extracts of medicinal plants and herbs for medical, veterinary and pharmaceutical purposes; foodstuffs for medicinal purposes, namely, medicated supplements for foodstuffs for babies and animals; herb teas for medicinal purposes
NOT AVAILABLE"BIOSCIENCES"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 16, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJAZZ PHARMACEUTICALS OPERATIONS UK LIMITED
Party Type32 - New Owner After Registration
Legal Entity Type24 - NOT AVAILABLE
AddressSITTINGBOURNE, KENT ME9 8AG
GB

Party NameGW PHARMA LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressCAMBRIDGE CB249BZ
GB

Party NameGW Research Limited
Party Type30 - Original Registrant
Legal Entity Type24 - NOT AVAILABLE
AddressHiston, Cambridge CB249BZ
GB

Party NameGW Research Limited
Party Type20 - Owner at Publication
Legal Entity Type24 - NOT AVAILABLE
AddressHiston, Cambridge CB249BZ
GB

Party NameGW Research Limited
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressHiston, Cambridge CB249BZ
GB

Trademark Events


Event DateEvent Description
Monday, May 30, 2016NEW APPLICATION ENTERED
Thursday, June 2, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 5, 2016NON-FINAL ACTION E-MAILED
Friday, June 24, 2016ASSIGNED TO EXAMINER
Tuesday, July 5, 2016NON-FINAL ACTION WRITTEN
Tuesday, July 5, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 28, 2016DIVISIONAL REQUEST RECEIVED
Thursday, July 28, 2016TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, August 10, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 15, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 15, 2016DIVISIONAL PROCESSING COMPLETE
Thursday, August 25, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 13, 2016ASSIGNED TO LIE
Tuesday, September 13, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 28, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 18, 2016PUBLISHED FOR OPPOSITION
Tuesday, October 18, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, May 25, 2017SOU TEAS EXTENSION RECEIVED
Thursday, May 25, 2017SOU EXTENSION 1 FILED
Thursday, May 25, 2017SOU EXTENSION 1 GRANTED
Saturday, May 27, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 20, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, September 20, 2017SOU EXTENSION 2 FILED
Wednesday, September 20, 2017SOU EXTENSION 2 GRANTED
Friday, September 22, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 29, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 29, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 5, 2018ASSIGNED TO EXAMINER
Friday, June 1, 2018TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, June 12, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, June 12, 2018SOU EXTENSION 3 FILED
Friday, June 15, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 15, 2018SOU EXTENSION 3 GRANTED
Saturday, June 16, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 29, 2018ASSIGNED TO PETITION STAFF
Friday, July 6, 2018PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Friday, July 6, 2018ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Wednesday, August 1, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 21, 2018PUBLISHED FOR OPPOSITION
Tuesday, August 21, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 6, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, September 15, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, September 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 15, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, September 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 15, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 16, 2018NOTICE OF ALLOWANCE CANCELLED
Wednesday, May 29, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, July 28, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, November 6, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, May 16, 2025CANCELLED SEC. 8 (6-YR)
Monday, February 24, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP